These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 34663207)

  • 1. CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study.
    Lorè NI; De Lorenzo R; Rancoita PMV; Cugnata F; Agresti A; Benedetti F; Bianchi ME; Bonini C; Capobianco A; Conte C; Corti A; Furlan R; Mantegani P; Maugeri N; Sciorati C; Saliu F; Silvestri L; Tresoldi C; ; Ciceri F; Rovere-Querini P; Di Serio C; Cirillo DM; Manfredi AA
    Mol Med; 2021 Oct; 27(1):129. PubMed ID: 34663207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring neutrophil-to-lymphocyte ratio in patients with coronavirus disease 2019 receiving tocilizumab.
    Hartog NL; Davis AT; Prokop JW; Walls A; Rajasekaran S
    Ann Allergy Asthma Immunol; 2021 Mar; 126(3):306-308. PubMed ID: 33387615
    [No Abstract]   [Full Text] [Related]  

  • 3. The value of clinical parameters in predicting the severity of COVID-19.
    Shang W; Dong J; Ren Y; Tian M; Li W; Hu J; Li Y
    J Med Virol; 2020 Oct; 92(10):2188-2192. PubMed ID: 32436996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.
    Li Y; Li H; Song C; Lu R; Zhao Y; Lin F; Han D; Chen L; Pan P; Dai M
    Dis Markers; 2021; 2021():6304189. PubMed ID: 34900028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implications of neutrophil-lymphocyte ratio in COVID-19.
    Jimeno S; Ventura PS; Castellano JM; García-Adasme SI; Miranda M; Touza P; Lllana I; López-Escobar A
    Eur J Clin Invest; 2021 Jan; 51(1):e13404. PubMed ID: 32918295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6-based mortality risk model for hospitalized patients with COVID-19.
    Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
    J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil-to-lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID-19.
    Liu L; Zheng Y; Cai L; Wu W; Tang S; Ding Y; Liu W; Kou G; Xiong Z; Wang S; Zheng S
    Int J Lab Hematol; 2021 Apr; 43(2):329-335. PubMed ID: 33099889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study.
    Hachim IY; Hachim MY; Hannawi H; Naeem KB; Salah A; Hannawi S
    PLoS One; 2021; 16(12):e0260537. PubMed ID: 34855832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy.
    Campi I; Gennari L; Merlotti D; Mingiano C; Frosali A; Giovanelli L; Torlasco C; Pengo MF; Heilbron F; Soranna D; Zambon A; Di Stefano M; Aresta C; Bonomi M; Cangiano B; Favero V; Fatti L; Perego GB; Chiodini I; Parati G; Persani L
    BMC Infect Dis; 2021 Jun; 21(1):566. PubMed ID: 34126960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
    Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
    Front Immunol; 2021; 12():700921. PubMed ID: 34539631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting mortality in geriatric patients hospitalized with COVID-19.
    Bağ Soytaş R; Ünal D; Arman P; Suzan V; Emiroğlu Gedik T; Can G; Korkmazer B; Karaali R; Börekçi Ş; Kuşkucu MA; Yavuzer H; Suna Erdinçler D; Döventaş A
    Turk J Med Sci; 2021 Apr; 51(2):454-463. PubMed ID: 33315348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein.
    Rizzi M; Costanzo M; Tonello S; Matino E; Casciaro FG; Croce A; Rizzi E; Zecca E; Pedrinelli A; Vassia V; Landi R; Bellan M; Castello LM; Minisini R; Mallela VR; Avanzi GC; Pirisi M; Lilleri D; Sainaghi PP
    Dis Markers; 2022; 2022():3528312. PubMed ID: 35242241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.
    Wang Z; Wang Z
    BMC Infect Dis; 2021 Jan; 21(1):113. PubMed ID: 33494706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epicardial adipose tissue, inflammatory biomarkers and COVID-19: Is there a possible relationship?
    Abrishami A; Eslami V; Baharvand Z; Khalili N; Saghamanesh S; Zarei E; Sanei-Taheri M
    Int Immunopharmacol; 2021 Jan; 90():107174. PubMed ID: 33208293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy.
    Ciceri F; Castagna A; Rovere-Querini P; De Cobelli F; Ruggeri A; Galli L; Conte C; De Lorenzo R; Poli A; Ambrosio A; Signorelli C; Bossi E; Fazio M; Tresoldi C; Colombo S; Monti G; Fominskiy E; Franchini S; Spessot M; Martinenghi C; Carlucci M; Beretta L; Scandroglio AM; Clementi M; Locatelli M; Tresoldi M; Scarpellini P; Martino G; Bosi E; Dagna L; Lazzarin A; Landoni G; Zangrillo A
    Clin Immunol; 2020 Aug; 217():108509. PubMed ID: 32535188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Systemic Inflammation Markers to Predict COVID-19 Prognosis.
    Karimi A; Shobeiri P; Kulasinghe A; Rezaei N
    Front Immunol; 2021; 12():741061. PubMed ID: 34745112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of simple and cost-effective immuno- haematological markers to predict outcome in hospitalized severe COVID-19 patients, with a focus on diabetes mellitus - A retrospective study in Andhra Pradesh, India.
    Ramesh J; Reddy SLS; Rajesh M; Varghese J
    Diabetes Metab Syndr; 2021; 15(3):739-745. PubMed ID: 33819728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of the neutrophil-to-lymphocyte ratio and C-reactive protein level for coronavirus disease 2019 (COVID-19).
    Yufei Y; Mingli L; Xuejiao L; Xuemei D; Yiming J; Qin Q; Hui S; Jie G
    Scand J Clin Lab Invest; 2020 Nov; 80(7):536-540. PubMed ID: 32804580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative Stress and Inflammatory Biomarkers for the Prediction of Severity and ICU Admission in Unselected Patients Hospitalized with COVID-19.
    Ducastel M; Chenevier-Gobeaux C; Ballaa Y; Meritet JF; Brack M; Chapuis N; Pene F; Carlier N; Szwebel TA; Roche N; Terrier B; Borderie D
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Leucocyte to High-Density Lipoprotein-Cholesterol Ratios in COVID-19 Patients and the Diabetes Subgroup.
    Wang Y; Zhang J; Li H; Kong W; Zheng J; Li Y; Wei Q; Li Q; Yang L; Xu Y; Li L; Wang H; Sun H; Xia W; Liu G; Zhong X; Qiu K; Wang H; Liu H; Song X; Xiong S; Liu Y; Cui Z; Chen L; Zeng T
    Front Endocrinol (Lausanne); 2021; 12():727419. PubMed ID: 34589058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.